FDA Approves GSK’s RSV Vaccine for Older Adults

The U.S. Food and Drug Administration approved the first vaccine against a common respiratory virus in older adults that has been a major cause of hospitalizations and deaths. The FDA on Wednesday cleared the vaccine from GSK for the prevention of lower respiratory tract diseases such as pneumonia…

#fda #gsk #rsv